Tumor size and survival in breast cancer--a reappraisal (Q37716590)

22 August 2017

1 reference

title

Tumor size and survival in breast cancer--a reappraisal (English)

1 reference

22 August 2017

author

William David Foulkes

object named as

William D Foulkes

series ordinal

1

0 references

Jorge Reis-Filho

series ordinal

2

object named as

Jorge S Reis-Filho

1 reference

22 August 2017

3

Steven A Narod

1 reference

22 August 2017

language of work or name

English

0 references

publication date

23 March 2010

1 reference

Nature Reviews Clinical Oncology

22 August 2017

published in

1 reference

22 August 2017

volume

7

1 reference

22 August 2017

issue

6

1 reference

22 August 2017

page(s)

348-353

1 reference

Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care?

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

Revision of the American Joint Committee on Cancer staging system for breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

Cancer of the breast: Size of neoplasm and prognosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

Implications from seer data on breast cancer management

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

Use of classical and novel biomarkers as prognostic risk factors for localised prostate cancer: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

Is cancer a disease of self-seeding?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

The molecular pathology of hereditary breast cancer: genetic testing and therapeutic implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

A basal epithelial phenotype is more frequent in interval breast cancers compared with screen detected tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

The development of interval breast malignancies in patients with BRCA mutations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

Basal-like breast cancer: a critical review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

Gene expression profiling predicts clinical outcome of breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

Gene-expression signatures in breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

Triple-negative breast cancer: clinical features and patterns of recurrence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

Use of immunohistochemical markers can refine prognosis in triple negative breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

Tumor size is an unreliable predictor of prognosis in basal-like breast cancers and does not correlate closely with lymph node status

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

Time to disease recurrence in basal-type breast cancers: effects of tumor size and lymph node status

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1-related breast carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

Clinical relevance of HER2 overexpression/amplification in patients with small tumor size and node-negative breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

Breast carcinoma presenting with axillary lymph node metastases. An analysis of specific histopathologic features

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

Cancer stem cells: an old idea--a paradigm shift

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

Heterogeneity in cancer: cancer stem cells versus clonal evolution

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

The epithelial-mesenchymal transition generates cells with properties of stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

The CD44+/CD24- phenotype is enriched in basal-like breast tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

Breast cancer metastasis: markers and models

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

Tiling path genomic profiling of grade 3 invasive ductal breast cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

Genomic and transcriptional aberrations linked to breast cancer pathophysiologies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

Integrated profiling of basal and luminal breast cancers.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

Complex landscapes of somatic rearrangement in human breast cancer genomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false-negative mammography

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

Basal phenotype: a powerful prognostic factor in small screen-detected invasive breast cancer with long-term follow-up.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

Sensitivity to first-line chemotherapy for metastatic breast cancer in BRCA1 and BRCA2 mutation carriers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.39

A Gompertzian model of human breast cancer growth.

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20309006

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Prediction of axillary lymph node involvement of women with invasive breast carcinoma: a multivariate analysis.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20309006

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20309006

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRCLINONC.2010.39

1 reference

22 August 2017

1 reference